Skip to main content
Trial shows positive results for Boston Scientific's Alair asthma device

A 284-patient postapproval study presented at the American Thoracic Society's annual meeting showed the use of Boston Scientific's Alair bronchial thermoplasty treatment device was associated with long-term improvement in asthma control. Treatment demonstrated a lower rate of severe exacerbations, from 77.8% to 50.6% at one year and to 45.4% at two years, as well as reductions in the rates of hospitalization and emergency department utilization.

Full Story: